North Star Investment Management’s GSK GSK Stock Holding History

North Star Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$521K	Buy	9,443 +9	+0.1%	+$488	0.03%	374
2025 Q4	$463K	Buy	9,434 +71	+0.8%	+$3.31K	0.03%	338
2025 Q3	$404K	Hold	9,363	–	–	0.03%	341
2025 Q2	$360K	Hold	9,363	–	–	0.03%	343
2025 Q1	$363K	Hold	9,363	–	–	0.03%	346
2024 Q4	$317K	Hold	9,363	–	–	0.02%	364
2024 Q3	$383K	Hold	9,363	–	–	0.03%	351
2024 Q2	$360K	Hold	9,363	–	–	0.03%	359
2024 Q1	$401K	Hold	9,363	–	–	0.03%	351
2023 Q4	$347K	Hold	9,363	–	–	0.03%	368
2023 Q3	$339K	Hold	9,363	–	–	0.03%	367
2023 Q2	$334K	Hold	9,363	–	–	0.03%	378
2023 Q1	$333K	Buy	9,363 +2,000	+27%	+$70K	0.03%	386
2022 Q4	$259K	Hold	7,363	–	–	0.02%	394
2022 Q3	$217K	Sell	7,363 -1	-0%	-$38	0.02%	364
2022 Q2	$401K	Hold	7,364	–	–	0.04%	318
2022 Q1	$401K	Sell	7,364 -774	-10%	-$42K	0.03%	323
2021 Q4	$449K	Buy	8,138 +482	+6%	+$25.1K	0.03%	316
2021 Q3	$366K	Hold	7,656	–	–	0.03%	328
2021 Q2	$381K	Hold	7,656	–	–	0.03%	320
2021 Q1	$342K	Hold	7,656	–	–	0.03%	313
2020 Q4	$352K	Hold	7,656	–	–	0.04%	299
2020 Q3	$360K	Hold	7,656	–	–	0.04%	295
2020 Q2	$390K	Sell	7,656 -748	-9%	-$38.4K	0.05%	263
2020 Q1	$398K	Hold	8,404	–	–	0.06%	239
2019 Q4	$494K	Hold	8,404	–	–	0.05%	270
2019 Q3	$448K	Hold	8,404	–	–	0.05%	275
2019 Q2	$420K	Hold	8,404	–	–	0.05%	290
2019 Q1	$439K	Hold	8,404	–	–	0.05%	286
2018 Q4	$401K	Sell	8,404 -800	-9%	-$39.4K	0.05%	269
2018 Q3	$462K	Buy	9,204 +800	+10%	+$40.6K	0.05%	269
2018 Q2	$423K	Hold	8,404	–	–	0.05%	279
2018 Q1	$410K	Hold	8,404	–	–	0.05%	281
2017 Q4	$373K	Sell	8,404 -120	-1%	-$5.54K	0.05%	281
2017 Q3	$433K	Buy	8,524 +40	+0.5%	+$2.03K	0.05%	271
2017 Q2	$457K	Hold	8,484	–	–	0.06%	261
2017 Q1	$447K	Hold	8,484	–	–	0.06%	256
2016 Q4	$408K	Buy	8,484 +1,900	+29%	+$93.9K	0.06%	252
2016 Q3	$355K	Buy	6,584 +80	+1%	+$4.39K	0.06%	239
2016 Q2	$352K	Sell	6,504 -160	-2%	-$8.43K	0.06%	243
2016 Q1	$338K	Sell	6,664 -160	-2%	-$7.97K	0.06%	243
2015 Q4	$344K	Hold	6,824	–	–	0.07%	240
2015 Q3	$328K	Hold	6,824	–	–	0.07%	243
2015 Q2	$355K	Hold	6,824	–	–	0.07%	240
2015 Q1	$394K	Hold	6,824	–	–	0.07%	232
2014 Q4	$365K	Buy	6,824 +1,224	+22%	+$68.5K	0.07%	226
2014 Q3	$322K	Sell	5,600 -400	-7%	-$24.5K	0.06%	231
2014 Q2	$401K	Hold	6,000	–	–	0.08%	217
2014 Q1	$401K	Hold	6,000	–	–	0.08%	215
2013 Q4	$400K	Hold	6,000	–	–	0.09%	229
2013 Q3	$376K	Buy	6,000 +400	+7%	+$25.7K	0.1%	203
2013 Q2	$350K	Buy	+5,600	New	+$355K	0.09%	208

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

North Star Investment Management's GSK Position: Q1 2026 in Review

North Star Investment Management increased its GSK (GSK) stake by 0.1% in Q1 2026, buying an estimated $488 and bringing the position to 9,443 shares worth $521K. The position accounts for 0.03% of the portfolio, ranked #374.

North Star Investment Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

North Star Investment Management held 9,443 shares of GSK worth $521K as of Q1 2026.
North Star Investment Management bought 9 GSK shares in Q1 2026, an estimated $488.
GSK made up 0.03% of North Star Investment Management's portfolio in Q1 2026, its #374 holding.
North Star Investment Management first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.